Recent research has highlighted the potential of NMN, a supplement that boosts NAD+ levels, to reverse certain aging effects. Dr. David Sinclair fr...
Scribe Therapeutics, a genetic medicines company, is set to participate in several major medical, scientific, and investor conferences throughout S...
A supplement known as NMN (nicotinamide mononucleotide) is being hailed as a potential 'fountain of youth' due to its ability to boost NAD+ levels,...
The medtech industry has experienced significant executive changes in 2025. Ashley McEvoy, previously with Johnson & Johnson MedTech, was appointed...
Anixa Biosciences, a biotechnology company specializing in cancer treatment and prevention, is set to participate in the H.C. Wainwright 27th Annua...
A study from the University of South Australia has found that common painkillers, ibuprofen and acetaminophen, contribute to antibiotic resistance....
Eli Lilly has announced promising results from a late-stage trial of its experimental GLP-1 pill, orforglipron, which led to an average weight loss...
Devonian Health Group Inc., a clinical stage pharmaceutical company, has provided a corporate update regarding its ongoing projects and financial a...
Testosterone replacement therapy (TRT) has seen a significant increase in usage among American men over the past two decades, often at doses exceed...
Argenx has announced positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a treatment for generalized myasthenia gravis (gMG). T...